BRUSSELS, Belgium - The European biotech industry is facing a long list of unmet priority tasks, according to its just-released 2008 annual report. (BioWorld International)

BRUSSELS, Belgium - There is a slowdown in the volume of useful new drugs on the European market, and biotech is in part to blame, according to the leading European pharmaceutical industry association. (BioWorld International)